fosfomycin and Adenocarcinoma

fosfomycin has been researched along with Adenocarcinoma* in 1 studies

Other Studies

1 other study(ies) available for fosfomycin and Adenocarcinoma

Article	Year
[Influence of a fosfomycin combination on the anti-tumor effect of CDDP]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:1 To elucidate the influence of fosfomycin (FOM) on the anti-cancer effect of cisplatin (CDDP), experimental chemotherapy of CDDP with or without FOM was performed. A human lung cancer cell line, HLC-1 serially transplanted into nude mice was treated with CDDP 10 mg/kg (i.p.). Tumor doubling time in CDDP group and CDDP + FOM group are 26.78 +/- 6.3 days and 33.90 +/- 11.82 days respectively, and they are significantly elongated compared to control group. Serum NAG level in CDDP + FOM group was significantly lowered. Therefore, we concluded that anti-tumor effect of CDDP was not diminished by FOM combination. Topics: Adenocarcinoma; Animals; Cisplatin; Drug Therapy, Combination; Female; Fosfomycin; Kidney Diseases; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation	1988

Article

Year

[Influence of a fosfomycin combination on the anti-tumor effect of CDDP].

Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:1

To elucidate the influence of fosfomycin (FOM) on the anti-cancer effect of cisplatin (CDDP), experimental chemotherapy of CDDP with or without FOM was performed. A human lung cancer cell line, HLC-1 serially transplanted into nude mice was treated with CDDP 10 mg/kg (i.p.). Tumor doubling time in CDDP group and CDDP + FOM group are 26.78 +/- 6.3 days and 33.90 +/- 11.82 days respectively, and they are significantly elongated compared to control group. Serum NAG level in CDDP + FOM group was significantly lowered. Therefore, we concluded that anti-tumor effect of CDDP was not diminished by FOM combination.

Topics: Adenocarcinoma; Animals; Cisplatin; Drug Therapy, Combination; Female; Fosfomycin; Kidney Diseases; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation

1988